18410408

Source:http://linkedlifedata.com/resource/pubmed/id/18410408

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0050559, umls-concept:C0087111, umls-concept:C0205191, umls-concept:C0406317, umls-concept:C0473169, umls-concept:C0717758, umls-concept:C2587213
pubmed:issue	6
pubmed:dateCreated	2008-5-16
pubmed:abstractText	Combination treatments may increase efficacy while reducing dosages and side-effects of individual agents. No randomized controlled trials have been published combining biologics with conventional agents for psoriasis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0004041
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acitretin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Keratolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1365-2133
pubmed:author	pubmed-author:CotenaCC, pubmed-author:Del GiglioMM, pubmed-author:GirolomoniGG, pubmed-author:GisondiPP
pubmed:issnType	Electronic
pubmed:volume	158
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1345-9
pubmed:meshHeading	pubmed-meshheading:18410408-Acitretin, pubmed-meshheading:18410408-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:18410408-Chronic Disease, pubmed-meshheading:18410408-Drug Administration Schedule, pubmed-meshheading:18410408-Drug Therapy, Combination, pubmed-meshheading:18410408-Female, pubmed-meshheading:18410408-Humans, pubmed-meshheading:18410408-Immunoglobulin G, pubmed-meshheading:18410408-Keratolytic Agents, pubmed-meshheading:18410408-Male, pubmed-meshheading:18410408-Middle Aged, pubmed-meshheading:18410408-Pilot Projects, pubmed-meshheading:18410408-Psoriasis, pubmed-meshheading:18410408-Quality of Life, pubmed-meshheading:18410408-Receptors, Tumor Necrosis Factor, pubmed-meshheading:18410408-Single-Blind Method, pubmed-meshheading:18410408-Time Factors, pubmed-meshheading:18410408-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
pubmed:affiliation	Department of Biomedical and Surgical Science, Section of Dermatology and Venereology, University of Verona, Piazzale A. Stefani 1, 37126 Verona, Italy. paolo.gisondi@univr.it
pubmed:publicationType	Journal Article, Randomized Controlled Trial